307 related articles for article (PubMed ID: 25909853)
1. Antiviral Activity of the Human Cathelicidin, LL-37, and Derived Peptides on Seasonal and Pandemic Influenza A Viruses.
Tripathi S; Wang G; White M; Qi L; Taubenberger J; Hartshorn KL
PLoS One; 2015; 10(4):e0124706. PubMed ID: 25909853
[TBL] [Abstract][Full Text] [Related]
2. Genetic characterization of circulating seasonal Influenza A viruses (2005-2009) revealed introduction of oseltamivir resistant H1N1 strains during 2009 in eastern India.
Agrawal AS; Sarkar M; Ghosh S; Roy T; Chakrabarti S; Lal R; Mishra AC; Chadha MS; Chawla-Sarkar M
Infect Genet Evol; 2010 Dec; 10(8):1188-98. PubMed ID: 20678590
[TBL] [Abstract][Full Text] [Related]
3. Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry.
Wu W; Li R; Li X; He J; Jiang S; Liu S; Yang J
Viruses; 2015 Dec; 8(1):. PubMed ID: 26712783
[TBL] [Abstract][Full Text] [Related]
4. Brevilin A, a Sesquiterpene Lactone, Inhibits the Replication of Influenza A Virus In Vitro and In Vivo.
Zhang X; Xia Y; Yang L; He J; Li Y; Xia C
Viruses; 2019 Sep; 11(9):. PubMed ID: 31500389
[TBL] [Abstract][Full Text] [Related]
5. Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza.
Huang CT; Hung CY; Hseih YC; Chang CS; Velu AB; He YC; Huang YL; Chen TA; Chen TC; Lin CY; Lin YC; Shih SR; Dutta A
Phytomedicine; 2019 Nov; 64():152904. PubMed ID: 31454654
[TBL] [Abstract][Full Text] [Related]
6. Neuraminidase Activity and Resistance of 2009 Pandemic H1N1 Influenza Virus to Antiviral Activity in Bronchoalveolar Fluid.
Ruangrung K; Suptawiwat O; Maneechotesuwan K; Boonarkart C; Chakritbudsabong W; Assawabhumi J; Bhattarakosol P; Uiprasertkul M; Puthavathana P; Wiriyarat W; Jongkaewwattana A; Auewarakul P
J Virol; 2016 May; 90(9):4637-4646. PubMed ID: 26912622
[TBL] [Abstract][Full Text] [Related]
7. Human H-ficolin inhibits replication of seasonal and pandemic influenza A viruses.
Verma A; White M; Vathipadiekal V; Tripathi S; Mbianda J; Ieong M; Qi L; Taubenberger JK; Takahashi K; Jensenius JC; Thiel S; Hartshorn KL
J Immunol; 2012 Sep; 189(5):2478-87. PubMed ID: 22851708
[TBL] [Abstract][Full Text] [Related]
8. Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010-2015.
Tewawong N; Marathe BM; Poovorawan Y; Vongpunsawad S; Webby RJ; Govorkova EA
PLoS One; 2018; 13(1):e0190877. PubMed ID: 29324781
[TBL] [Abstract][Full Text] [Related]
9. The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins.
Tripathi S; Tecle T; Verma A; Crouch E; White M; Hartshorn KL
J Gen Virol; 2013 Jan; 94(Pt 1):40-49. PubMed ID: 23052388
[TBL] [Abstract][Full Text] [Related]
10. Antiviral susceptibility profile of influenza A viruses; keep an eye on immunocompromised patients under prolonged treatment.
Kossyvakis A; Mentis AA; Tryfinopoulou K; Pogka V; Kalliaropoulos A; Antalis E; Lytras T; Meijer A; Tsiodras S; Karakitsos P; Mentis AF
Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):361-371. PubMed ID: 27848039
[TBL] [Abstract][Full Text] [Related]
11. Collectins, H-ficolin and LL-37 reduce influence viral replication in human monocytes and modulate virus-induced cytokine production.
White MR; Tripathi S; Verma A; Kingma P; Takahashi K; Jensenius J; Thiel S; Wang G; Crouch EC; Hartshorn KL
Innate Immun; 2017 Jan; 23(1):77-88. PubMed ID: 27856789
[TBL] [Abstract][Full Text] [Related]
12. Emergence and phylogenetic relationships of amantadine-resistant human H3N2 influenza A viruses in Germany in the season 2005/2006.
Schmidtke M; Bauer K; Ludwig N; Wutzler P
Int J Antimicrob Agents; 2008 Aug; 32(2):192-5. PubMed ID: 18571381
[No Abstract] [Full Text] [Related]
13. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
Dapat C; Kondo H; Dapat IC; Baranovich T; Suzuki Y; Shobugawa Y; Saito K; Saito R; Suzuki H
Antiviral Res; 2013 Sep; 99(3):261-9. PubMed ID: 23791870
[TBL] [Abstract][Full Text] [Related]
14. In vitro anti-influenza A activity of interferon (IFN)-λ1 combined with IFN-β or oseltamivir carboxylate.
Ilyushina NA; Donnelly RP
Antiviral Res; 2014 Nov; 111():112-20. PubMed ID: 25245230
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity of novel oseltamivir derivatives against some influenza virus strains.
Kocik J; Kołodziej M; Joniec J; Kwiatek M; Bartoszcze M
Acta Biochim Pol; 2014; 61(3):509-13. PubMed ID: 25210935
[TBL] [Abstract][Full Text] [Related]
16. Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses.
Park JG; Ávila-Pérez G; Nogales A; Blanco-Lobo P; de la Torre JC; Martínez-Sobrido L
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941776
[TBL] [Abstract][Full Text] [Related]
17. Role of the viral hemagglutinin in the anti-influenza virus activity of newly synthesized polycyclic amine compounds.
Torres E; Duque MD; Vanderlinden E; Ma C; Pinto LH; Camps P; Froeyen M; Vázquez S; Naesens L
Antiviral Res; 2013 Sep; 99(3):281-91. PubMed ID: 23800838
[TBL] [Abstract][Full Text] [Related]
18. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.
Sheu TG; Deyde VM; Okomo-Adhiambo M; Garten RJ; Xu X; Bright RA; Butler EN; Wallis TR; Klimov AI; Gubareva LV
Antimicrob Agents Chemother; 2008 Sep; 52(9):3284-92. PubMed ID: 18625765
[TBL] [Abstract][Full Text] [Related]
19. Mutations flanking the carbohydrate binding site of surfactant protein D confer antiviral activity for pandemic influenza A viruses.
Nikolaidis NM; White MR; Allen K; Tripathi S; Qi L; McDonald B; Taubenberger J; Seaton BA; McCormack FX; Crouch EC; Hartshorn KL
Am J Physiol Lung Cell Mol Physiol; 2014 Jun; 306(11):L1036-44. PubMed ID: 24705721
[TBL] [Abstract][Full Text] [Related]
20. Genetic characterisation of influenza A(H1N1)pdm09 viruses circulating in Assam, Northeast India during 2009-2015.
Biswas D; Dutta M; Sarmah K; Yadav K; Buragohain M; Sarma K; Borkakoty B
Indian J Med Microbiol; 2019; 37(1):42-49. PubMed ID: 31424009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
